Sponsored By
Dr. Tia Lyles-Williams, Chief Executive Officer of Philadelphia-based LucasPye Bio (LPB), a biologics contract development and manufacturing organization (CDMO), is...
Read more
What caught Idera’s attention was Aceragen’s lead assets, including ACG-701, which is set to enter phase 2 trials later this...
Eagle Pharmaceuticals is keeping an eye on Enalare Therapeutics’ lead respiratory candidate, and apparently, so is the US government. The...
In a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories, the Philadelphia region...
As long overdue change takes shape and the number of women in the biotech industry continues to grow, it is...
